Publications of T. Pollmächer
All genres
Journal Article (181)
61.
Journal Article
29 (8), pp. 1462 - 1469 (2004)
Clozapine alters sleep-wake behavior in rats. Neuropsychopharmacology 62.
Journal Article
18 (4), pp. 361 - 367 (2004)
Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Brain Behavior and Immunity 63.
Journal Article
286 (6), pp. E963 - E967 (2004)
Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. American Journal of Physiology-Endocrinology and Metabolism 64.
Journal Article
38 (2), pp. 219 - 221 (2004)
Long-latency somatosensory potentials in high risk probands for affective disorders. Journal of Psychiatric Research 65.
Journal Article
75 (3), pp. 215 - 226 (2004)
Cytokine networks in patients with schizophrenia and their possible role in its pathophysiology. Nervenarzt 66.
Journal Article
14 (Suppl. 1), p. S49 - S49 (2004)
Brain networks in sleep as revealed by combined EEG and fMRI. European Neuropsychopharmacology 67.
Journal Article
20, pp. 566 - 574 (2004)
Functional MRI during sleep: BOLD signal decreases and their electrophysiological correlates. European Journal of Neuroscience 68.
Journal Article
29, pp. 851 - 860 (2004)
Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers. Psychoneuroendocrinology 69.
Journal Article
23 (2), pp. 110 - 115 (2004)
Effects of inflammatory cytokines on affect and cognition. Nervenheilkunde 70.
Journal Article
61 (6), pp. 864 - 865 (2003)
Successful suppression of cataplectic attacks with tramadol. Neurology 71.
Journal Article
36 (5), p. 218 - 218 (2003)
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study. Pharmacopsychiatry 72.
Journal Article
36 (5), p. 218 - 218 (2003)
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Pharmacopsychiatry 73.
Journal Article
36 (5), pp. 234 - 235 (2003)
Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain. Pharmacopsychiatry 74.
Journal Article
36 (5), p. 235 - 235 (2003)
Body weight and the plasma levels of leptin and enclogenous immune modulators during treatment with carbamazepine or lithium. Pharmacopsychiatry 75.
Journal Article
36 (5), p. 235 - 235 (2003)
Epidemiology and mechanisms of weight gain induced by psychotropic drugs. Pharmacopsychiatry 76.
Journal Article
36 (5), p. 235 - 235 (2003)
Early prediction of changes in weight during six weeks of treatment with antidepressants. Pharmacopsychiatry 77.
Journal Article
36 (5), p. 263 - 263 (2003)
Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders. Pharmacopsychiatry 78.
Journal Article
36 (5), pp. 263 - 264 (2003)
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects - First results from a double-blind, placebocontrolled study. Pharmacopsychiatry 79.
Journal Article
36 (5), p. 264 - 264 (2003)
Influence of sleep deprivation on plasma ghrelin levels in healthy subjects. Pharmacopsychiatry 80.
Journal Article
36 (5), p. 271 - 271 (2003)
Different brain reactivity during phasic and tonic REM sleep: A simultaneous fMRI and EEG study. Pharmacopsychiatry